POS0322 INVESTIGATING THE IMPACT OF DEUCRAVACITINIB TREATMENT ON CARDIOVASCULAR RISK-ASSOCIATED BIOMARKERS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE PHASE 2 PAISLEY STUDY
用户lwEnaAB_Z2_E
1小时前
49
10
已关闭
DOI: 10.1016/j.ard.2025.05.709
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S000349672501742X
其他信息:
出版社: Elsevier BV
作者: B. Weber; C. Charles-Schoeman; L. Gao; E. Morand; J.M. Kahlenberg; M. Garshick; J. Zrubek; I. Catlett; P. Schafer; X. Chen; C. Wu; J. Liu

